-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Absci (NASDAQ:ABSI) Shares Up 1%
Absci (NASDAQ:ABSI) Shares Up 1%
Shares of Absci Co. (NASDAQ:ABSI – Get Rating) traded up 1% during mid-day trading on Tuesday . The company traded as high as $3.25 and last traded at $3.12. 466,859 shares were traded during trading, a decline of 0% from the average session volume of 468,491 shares. The stock had previously closed at $3.09.
Absci Price Performance
The stock's 50-day moving average is $2.49 and its 200-day moving average is $3.12. The firm has a market cap of $304.90 million, a P/E ratio of -2.65 and a beta of 0.62. The company has a quick ratio of 6.71, a current ratio of 6.71 and a debt-to-equity ratio of 0.03.
Get Absci alerts:Absci (NASDAQ:ABSI – Get Rating) last issued its earnings results on Wednesday, November 9th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $2.37 million during the quarter, compared to analyst estimates of $1.79 million. Absci had a negative net margin of 1,960.28% and a negative return on equity of 33.62%. As a group, equities analysts anticipate that Absci Co. will post -1.13 EPS for the current fiscal year.
Hedge Funds Weigh In On Absci
Several institutional investors and hedge funds have recently modified their holdings of ABSI. D Orazio & Associates Inc. bought a new stake in Absci in the 4th quarter valued at $32,000. Metropolitan Life Insurance Co NY acquired a new stake in Absci in the first quarter valued at about $33,000. Two Sigma Advisers LP acquired a new stake in Absci in the third quarter valued at about $34,000. Ameritas Investment Partners Inc. boosted its stake in Absci by 305.3% in the first quarter. Ameritas Investment Partners Inc. now owns 4,312 shares of the company's stock valued at $36,000 after buying an additional 3,248 shares in the last quarter. Finally, ProShare Advisors LLC acquired a new stake in Absci in the third quarter valued at about $42,000. 47.59% of the stock is currently owned by institutional investors and hedge funds.Absci Company Profile
(Get Rating)
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.
Read More
- Get a free copy of the StockNews.com research report on Absci (ABSI)
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- The Future Of E-Commerce: Analysis And New Data
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
Receive News & Ratings for Absci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci and related companies with MarketBeat.com's FREE daily email newsletter.
Shares of Absci Co. (NASDAQ:ABSI – Get Rating) traded up 1% during mid-day trading on Tuesday . The company traded as high as $3.25 and last traded at $3.12. 466,859 shares were traded during trading, a decline of 0% from the average session volume of 468,491 shares. The stock had previously closed at $3.09.
阿布西利公司的股份(納斯達克:ABSI — 獲得評級) 在星期二中午交易期間交易上漲 1%。該公司的交易價格高達 3.25 美元,最後成交價為 3.12 美元。在交易期間交易了 466,859 股,較 468,491 股的平均交易量下跌 0%。該股票之前已收盤 3.09 美元。
Absci Price Performance
阿布西利價格表現
The stock's 50-day moving average is $2.49 and its 200-day moving average is $3.12. The firm has a market cap of $304.90 million, a P/E ratio of -2.65 and a beta of 0.62. The company has a quick ratio of 6.71, a current ratio of 6.71 and a debt-to-equity ratio of 0.03.
該股票的 50 天移動平均線為 2.49 美元,其 200 天移動平均線為 3.12 美元。該公司的市值為 304.90 萬美元,市盈率為 -2.65,貝塔值為 0.62。該公司的快速比率為 6.71,流動比率為 6.71,債務與權益比率為 0.03。
Absci (NASDAQ:ABSI – Get Rating) last issued its earnings results on Wednesday, November 9th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $2.37 million during the quarter, compared to analyst estimates of $1.79 million. Absci had a negative net margin of 1,960.28% and a negative return on equity of 33.62%. As a group, equities analysts anticipate that Absci Co. will post -1.13 EPS for the current fiscal year.
Absci (納斯達克:ABSI — 獲得評級) 上次公佈其盈利業績日期為 11 月 9 日(星期三)。該公司報告了本季度每股收益(0.30 美元),缺少了(0.27 美元)的共識估計(0.03 美元)。該公司在本季度的收入為 237 萬美元,而分析師估計為 1.79 萬美元。阿布西利的負淨利潤率為 1,960.28%,而負資產回報率則為 33.62%。作為一個集團,股票分析師預計 Absci Co. 將在本會計年度投入 -1.13 每股盈利。
Hedge Funds Weigh In On Absci
對沖基金權衡 Absci
Absci Company Profile
阿布西公司簡介
(Get Rating)
(取得評分)
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.
Absci Corporation 是一家藥物和標靶發現公司,為美國的合作夥伴使用綜合藥物創造平台為生物製藥和生產細胞系提供。其集成的藥物創造平台通過將藥物發現和細胞系開發過程統一為一個過程來實現生物製劑的創建。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on Absci (ABSI)
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- The Future Of E-Commerce: Analysis And New Data
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
- 免費獲取有關亞布西股份有限公司(ABSI)的研究報告
- 雪佛龍以 750 億美元的股份回購令股東感到滿意
- 電子商務的未來:分析與新數據
- 列維·施特勞斯是一個非常適合收入投資者
- 3 個有大上升空間的小型大寫字母
- 馬倫汽車:好消息,壞的和醜陋的前景
Receive News & Ratings for Absci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Absci 日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Absci 及相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧